← Eichor
Study identifier: NCT06513650 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mechanism-based Therapy of Hypotensive Syncope

Condition: Syncope, Vasovagal, Neurally-Mediated  ·  Sponsor: Istituto Auxologico Italiano

PhaseN/A
Planned participants140
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of this study is to assess the efficacy of a therapeutic strategy aimed to increase 24-hour systolic blood pressure (SBP) values, assessed by 24-hour ambulatory blood pressure monitoring (ABPM), in reducing syncope recurrences in patients affected by hypotensive syncope during one year of follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Michele Brignole, MD Cardiologist  ·  +3204391422  ·  m.brignole@auxologico.it

Antonella Groppelli, MD  ·  +393388732063  ·  a.groppelli@auxologico.it

Always discuss trial participation with your own doctor first.

Locations (9)

University of marseille Aix en ProvenceMarseille, FranceRecruiting
IRCCS Istituto Auxologico ItalianoMilan, MI, ItalyRecruiting
IRCCS Istituto Auxologico ItalianoMilan, MI, ItalyRecruiting
University of FlorenceFlorence, ItalyRecruiting
ospdali del TigullioLavagna, ItalyRecruiting
Università della Campania VamvitelliNaples, ItalyRecruiting
AMC Universisty of AmsterdamAmsterdam, NetherlandsRecruiting
University of Barcelona Vall d'EbronBarcelona, SpainNot Yet Recruiting
Karolinska InstitutStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06513650